Fortress Biotech Inc (FBIO)
1.79
+0.04
(+2.29%)
USD |
NASDAQ |
May 06, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Price: 1.79 for May 6, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 1.85 | 1.86 | 1.67 | 1.75 | 177764.0 |
May 02, 2024 | 1.75 | 1.81 | 1.70 | 1.80 | 116076.0 |
May 01, 2024 | 1.70 | 1.77 | 1.67 | 1.74 | 112948.0 |
Apr 30, 2024 | 1.71 | 1.731 | 1.66 | 1.67 | 92172.00 |
Apr 29, 2024 | 1.70 | 1.75 | 1.66 | 1.72 | 117843.0 |
Apr 26, 2024 | 1.71 | 1.79 | 1.70 | 1.72 | 104621.0 |
Apr 25, 2024 | 1.75 | 1.77 | 1.66 | 1.72 | 210123.0 |
Apr 24, 2024 | 1.79 | 1.80 | 1.76 | 1.79 | 115102.0 |
Apr 23, 2024 | 1.79 | 1.82 | 1.76 | 1.81 | 193142.0 |
Apr 22, 2024 | 1.73 | 1.78 | 1.73 | 1.75 | 151080.0 |
Apr 19, 2024 | 1.86 | 1.86 | 1.71 | 1.75 | 186744.0 |
Apr 18, 2024 | 1.79 | 1.88 | 1.70 | 1.81 | 437483.0 |
Apr 17, 2024 | 1.79 | 1.84 | 1.762 | 1.77 | 245098.0 |
Apr 16, 2024 | 1.76 | 1.81 | 1.73 | 1.76 | 193443.0 |
Apr 15, 2024 | 1.82 | 1.84 | 1.72 | 1.82 | 336212.0 |
Apr 12, 2024 | 1.83 | 1.87 | 1.72 | 1.80 | 266269.0 |
Apr 11, 2024 | 1.92 | 1.92 | 1.77 | 1.82 | 202001.0 |
Apr 10, 2024 | 1.89 | 1.93 | 1.80 | 1.91 | 184452.0 |
Apr 09, 2024 | 1.98 | 1.98 | 1.85 | 1.89 | 181432.0 |
Apr 08, 2024 | 1.84 | 1.940 | 1.76 | 1.90 | 201345.0 |
Apr 05, 2024 | 1.88 | 1.90 | 1.631 | 1.87 | 396312.0 |
Apr 04, 2024 | 1.92 | 1.93 | 1.85 | 1.87 | 196588.0 |
Apr 03, 2024 | 1.94 | 1.94 | 1.83 | 1.92 | 179481.0 |
Apr 02, 2024 | 1.94 | 1.96 | 1.79 | 1.93 | 203325.0 |
Apr 01, 2024 | 2.05 | 2.053 | 1.92 | 1.99 | 334925.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.31
Minimum
Nov 10 2023
82.20
Maximum
Apr 12 2021
27.14
Average
24.00
Median
May 13 2019
Price Benchmarks
Journey Medical Corp | 3.57 |
Avenue Therapeutics Inc | 4.54 |
Mustang Bio Inc | 0.3044 |
Checkpoint Therapeutics Inc | 1.63 |
Viking Therapeutics Inc | 78.27 |
Price Related Metrics
PS Ratio | 0.1717 |
Price to Book Value | 1.527 |
Earnings Yield | -459.0% |
Market Cap | 34.43M |